Investor Alert: Class Action Lawsuits Initiated Against HireRight, Ocugen, Sonder, and QuidelOrtho

Shareholder Litigation Commencement

Bragar Eagel & Squire, P.C., a distinguished shareholder rights law firm, has issued a reminder to investors of HRT, OCGN, SOND, and QDEL that class action lawsuits have been filed on behalf of shareholders. The firm is urging afflicted investors to get in touch to learn about their legal rights and options in this matter.

About the Companies Involved

HRT, known as Arrhythmia Research Technology, Inc., along with its subsidiary Micron Products, Inc., is recognized for its expertise in plastic molding, precision machining, and precious metal coating. SOND, representing Sonder Holdings Inc., operates within the hospitality sector and is based out of San Francisco. On the healthcare front, OCGN, or Ocugen, Inc., is entrenched in the development of gene therapies to address blindness with its clinical-stage biopharmaceutical endeavors. Lastly, QDEL, which refers to Quidel Corporation, specializes in the creation, manufacture, and distribution of diagnostic testing solutions across a diverse range of medical fields globally, with roots in San Diego.

Legal Proceedings Initiation

The initiation of class action lawsuits is in response to perceived discrepancies and alleged legal violations related to investor rights. Those who have invested in these companies are encouraged to assess the class action claim details and consider contacting Bragar Eagel & Squire, P.C. to join the lawsuit or to obtain additional information concerning the case.

lawsuit, investor, reminder